The aminase oxidase inhibitors. Their current place in clinical medicine.
Development of the MAO-inhibitors has been an important advance in the treatment of tuberculosis, mental depression, several of the collagen diseases, hypertension and angina pectoris. Treatment must be carefully controlled and individualized. A sufficient number of MAO-inhibitors is available at present to afford ready and correct selection of the proper one for a given patient and disease. Provided such care is observed, treatment is most successful and side effects are few and, as a rule, readily corrected.
D000787:Angina Pectoris / Q000628:therapy*; D000959:Antihypertensive Agents; D006834:Hydrazines; D006973:Hypertension; D008996:Monoamine Oxidase Inhibitors; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*
D000959:Antihypertensive Agents; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D010088:Oxidoreductases
ANGINA PECTORIS/therapy; OXIDASES/antagonists